Matthew Austin
Professor at Cell Biology, Yale University8 Followers
Dr. Matthew Austin is a distinguished Assistant Clinical Professor of Medicine in the field of Medical Oncology at the Yale School of Medicine. He is renowned for his expertise in treating melanoma and genitourinary cancers, providing care to patients at the Smilow Cancer Hospital Care Centers. His practice spans across Westerly, Rhode Island, and Waterford, Connecticut, where he is dedicated to offering personalized and cutting-edge treatment options.
Dr. Austin's academic journey began with a medical degree from the University at Buffalo School of Medicine. He further honed his skills during his residency at Brown University, where he was appointed as Chief Resident, a testament to his leadership and clinical acumen. His commitment to advancing cancer treatment is reflected in his research interests, which focus on the development of innovative therapies for melanoma and genitourinary cancers.
A key area of Dr. Austin's research is the exploration of immunotherapy as a promising treatment modality. He is actively involved in clinical trials and collaborative research efforts aimed at enhancing the efficacy and safety of immunotherapeutic approaches. His work seeks to bridge the gap between laboratory discoveries and clinical applications, ultimately improving patient outcomes.
In addition to his clinical and research endeavors, Dr. Austin is a dedicated educator, mentoring medical students and residents at Yale. He is passionate about fostering the next generation of oncologists, emphasizing the importance of integrating research with clinical practice. His teaching philosophy is grounded in encouraging critical thinking and a patient-centered approach to care.
Dr. Austin's contributions to the field of oncology have been recognized through various awards and publications. He is a sought-after speaker at national and international conferences, where he shares his insights on the latest advancements in cancer treatment. His commitment to excellence in patient care and research continues to drive his efforts in the fight against cancer.
External Link www.yale.edu/ Dr. Austin's academic journey began with a medical degree from the University at Buffalo School of Medicine. He further honed his skills during his residency at Brown University, where he was appointed as Chief Resident, a testament to his leadership and clinical acumen. His commitment to advancing cancer treatment is reflected in his research interests, which focus on the development of innovative therapies for melanoma and genitourinary cancers.
A key area of Dr. Austin's research is the exploration of immunotherapy as a promising treatment modality. He is actively involved in clinical trials and collaborative research efforts aimed at enhancing the efficacy and safety of immunotherapeutic approaches. His work seeks to bridge the gap between laboratory discoveries and clinical applications, ultimately improving patient outcomes.
In addition to his clinical and research endeavors, Dr. Austin is a dedicated educator, mentoring medical students and residents at Yale. He is passionate about fostering the next generation of oncologists, emphasizing the importance of integrating research with clinical practice. His teaching philosophy is grounded in encouraging critical thinking and a patient-centered approach to care.
Dr. Austin's contributions to the field of oncology have been recognized through various awards and publications. He is a sought-after speaker at national and international conferences, where he shares his insights on the latest advancements in cancer treatment. His commitment to excellence in patient care and research continues to drive his efforts in the fight against cancer.
Publications
6 - “HE WHO IS UNABLE TO LIVE IN SOCIETY . . . MUST EITHER BE A BEAST OR A GOD”: SITUATING THE “INHUMAN” IN ARISTOTLE’S POLITICAL THOUGHT,eTopia
Matthew James Austin ,
, 2008-10-04
12 - Darbepoetin Alfa for the Treatment of Chemotherapy-Induced Anemia: Disease Progression and Survival Analysis From Four Randomized, Double-Blind, Placebo-Controlled Trials,Journal of Clinical Oncology
Michael Hedenus , Johan Vansteenkiste , Dusan Kotasek , Matthew Austin , Rafael G. Amado ,
, 6941-6948, 2005-10-01
Share Matthew's Profile
